Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype.

Content Provider	Semantic Scholar
Author	März, Winfred Scharnagl, Hubert Abletshauser, C. Hoffmann, Michael Marcus Berg, Aloys Keul, Joseph Wieland, Heinrich
Copyright Year	2001
Abstract	BACKGROUND Although HMG-CoA reductase inhibitors (HMGRIs) are effective lipid-lowering agents, it remains controversial whether these agents also lower dense LDL (dLDL), a predominance of which is considered to contribute to the atherogenicity of the metabolic syndrome. METHODS AND RESULTS In a multicenter, double-blind, randomized, placebo-controlled study, we determined the effect of the HMGRI fluvastatin on lipids, apolipoproteins, and LDL subfractions (by equilibrium density gradient ultracentrifugation). A total of 52 postmenopausal women with combined hyperlipidemia and increased dLDL were treated with either fluvastatin 40 mg/d (n=35) or placebo (n=17). After 12 weeks' treatment, significant reductions (P<0.001) in total cholesterol (-19%), IDL cholesterol (-35%), LDL cholesterol (-23%), apolipoprotein B (-21%), and apolipoprotein B in dLDL (-42%) were apparent among fluvastatin recipients. No significant changes in triglycerides or HDL cholesterol were observed. The effect of fluvastatin on dLDL was correlated with baseline values. There was no consistent relationship, however, between the effect of fluvastatin on triglycerides and the decrease in dLDL. CONCLUSIONS Fluvastatin lowers total and LDL cholesterol and the concentration of dLDL. This profile may contribute to an antiatherogenic effect for fluvastatin that is greater than expected on the basis of changes in lipids and apolipoproteins.
File Format	PDF HTM / HTML
Alternate Webpage(s)	http://circ.ahajournals.org/content/circulationaha/103/15/1942.full.pdf
Alternate Webpage(s)	http://circ.ahajournals.org/content/circulationaha/103/15/1942.full.pdf?download=true
PubMed reference number	11306521v1
Volume Number	103
Issue Number	15
Journal	Circulation
Language	English
Access Restriction	Open
Subject Keyword	Apolipoproteins B Centrifugation, Density Gradient Cholesterol Hydroxymethylglutaryl-CoA reductase Hyperlipidemia Low-Density Lipoproteins Metabolic Syndrome X Triglycerides Ultracentrifugation fluvastatin
Content Type	Text
Resource Type	Article